Cargando…
Neutropenia Secondary to SARS-Cov2 Vaccination in Post-Hematopoietic Stem Cell Transplant (HSCT) Patients
Autores principales: | Juárez-Salcedo, LM, Feijóo Monroy, S, García-Herce, C, Alonso, A, Aguado, B, Ortiz, J, Figuera, A, Cámara, JR |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000821/ https://www.ncbi.nlm.nih.gov/pubmed/36908872 http://dx.doi.org/10.4084/MJHID.2023.014 |
Ejemplares similares
-
COVID-19 and HSCT (Hematopoietic stem cell transplant)
por: Strasfeld, Lynne
Publicado: (2022) -
Establishing the hematopoietic stem cell transplant (HSCT) in a developing country; the journey of HSCT in Semarang, Indonesia
por: Santosa, Damai, et al.
Publicado: (2020) -
2487. Vaccination Rates in Post-Transplant Hematopoietic Stem Cell Transplant (HSCT) Patients: Where Do We Stand?
por: Ahmad, Hiba, et al.
Publicado: (2018) -
The impact of viral respiratory infections in the first year post-transplant period of pediatric hematopoietic stem cell transplant (HSCT) recipients
por: Piralla, Antonio, et al.
Publicado: (2016) -
Vancomycin Pharmacokinetic Parameters in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
por: Ghehi, Maryam Taghizadeh, et al.
Publicado: (2013)